The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Mucosal Immunol. 2022 May;15(5):809-818. doi: 10.1038/s41385-022-00539-2. Epub 2022 Jun 22.
Despite compartmentalization within the lumen of the gastrointestinal tract, the gut microbiota has a far-reaching influence on immune cell development and function throughout the body. This long-distance relationship is crucial for immune homeostasis, including effective host defense against invading pathogens that cause systemic infections. Herein, we review new insights into how commensal microbes that are spatially restricted to the gut lumen can engage in long-distance relationships with innate and adaptive immune cells at systemic sites to fortify host defenses against infections. In addition, we explore the consequences of intestinal dysbiosis on impaired host defense and immune-mediated pathology during infections, including emerging evidence linking dysbiosis with aberrant systemic inflammation and immune-mediated organ damage in sepsis. As such, therapeutic modification of the gut microbiota is an emerging target for interventions to prevent and/or treat systemic infections and sepsis by harnessing the long-distance relationships between gut microbes and systemic immunity.
尽管胃肠道管腔内部存在分隔,肠道微生物群仍对全身免疫细胞的发育和功能具有深远的影响。这种远距离关系对于免疫稳态至关重要,包括有效抵御引起全身感染的入侵病原体的宿主防御。在此,我们综述了新的见解,即局限于肠道管腔的共生微生物如何与全身部位的固有和适应性免疫细胞进行远距离相互作用,以加强宿主对感染的防御。此外,我们探讨了肠道菌群失调对感染期间宿主防御受损和免疫介导的病理的影响,包括将菌群失调与败血症中异常的全身炎症和免疫介导的器官损伤联系起来的新证据。因此,通过利用肠道微生物群和全身免疫之间的远距离关系,治疗性修饰肠道微生物群是预防和/或治疗全身感染和败血症的新兴干预靶点。